It has been a mixed year for NextCure, Inc. insiders: $1.7 million bought by one person and $185,000 sold by one, so more buying than selling overall.
ADAR1 Capital Management, LLC (10% Owner) made the biggest buy, worth around $490,000.
Big money check: 30 institutions held NXTC as of Q2 2026, and more funds bought than sold. Zooming out by quarter: Last full quarter: net buying by insiders. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. | Other | Sell | 30,000 | $6.16 | $185K | SEC |
| Aug 3, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 50,000 | $4.97 | $248K | SEC |
| Aug 3, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 20,000 | $5.00 | $100K | SEC |
| Aug 3, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 20,000 | $5.00 | $100K | SEC |
| Aug 3, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 25,000 | $4.81 | $120K | SEC |
| Aug 3, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 8,003 | $4.80 | $38K | SEC |
| Aug 3, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 77,850 | $4.96 | $386K | SEC |
| Aug 3, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 3,300 | $4.98 | $16K | SEC |
| Aug 3, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 25,000 | $4.98 | $124K | SEC |
| Aug 3, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 100,000 | $4.90 | $490K | SEC |
| Jul 29, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 1,810 | $5.00 | $9K | SEC |
| Jul 29, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 6,400 | $4.95 | $32K | SEC |
| Jul 29, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 7,798 | $5.00 | $39K | SEC |
| Jul 29, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 1,600 | $5.00 | $8K | SEC |
In the last 12 months NextCure, Inc. insiders made open-market purchases worth about $1.7 million and sales worth about $185,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in NXTC was filed on 2026-08-12.
30 investment managers reported holding NXTC in SEC Form 13F filings for Q2 2026.
No congressional trades in NXTC were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).